Literature DB >> 444017

Differentiation of primary affective illness from situational, symptomatic, and secondary depressions.

H S Akiskal, R H Rosenthal, T L Rosenthal, M Kashgarian, M K Khani, V R Puzantian.   

Abstract

Analysis of family history and antidepressant drug response variables of 100 "neurotic" depressives followed up prospectively over three to four years disclosed that primary depressions (unipolar and bipolar) could be distinguished from nonprimary cases by (1) the early occurrence of "pharmacological-hypomania;" (2) family history of bipolar illness; (3) family history for affective disorder in two or three consecutive generations, especially when "loaded." Although each of these variables alone occurred in only one fifth to one third of the primary group, they individually displayed better than 95% specificity for it. Thus, the confidence with which the diagnosis of primary affective illness could be made in the presence of any of these variables ranged from 88% to 100%. These findings argue for considering such nonsymptomatological variables for their potential in strengthening the phenomenologic diagnostic criteria for depressive illness.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444017     DOI: 10.1001/archpsyc.1979.01780060025002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  15 in total

1.  Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression.

Authors:  Jess G Fiedorowicz; Jean Endicott; David A Solomon; Martin B Keller; William H Coryell
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

Review 2.  Prospective: Is bipolar disorder being overdiagnosed?

Authors:  Tammas Kelly
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

3.  A clinical study of chronic depression.

Authors:  S Singhal; S Kumar; A K Agarwal
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

Review 4.  Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.

Authors:  Dan V Iosifescu; Bettina Bankier; Maurizio Fava
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

5.  Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Psychiatr Res       Date:  2013-07-18       Impact factor: 4.791

6.  Psychopathology in the families of inpatient affective disordered adolescents.

Authors:  C M Borchardt; G A Bernstein; R D Crosby
Journal:  Child Psychiatry Hum Dev       Date:  1995

7.  A cross-cultural study of depressive symptomology.

Authors:  W C Chang
Journal:  Cult Med Psychiatry       Date:  1985-09

8.  Conversion from bipolar disorder not otherwise specified (BP-NOS) to bipolar I or II in youth with family history as a predictor of conversion.

Authors:  Molly S Martinez; Mary A Fristad
Journal:  J Affect Disord       Date:  2012-09-05       Impact factor: 4.839

9.  Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzu-Yun Wang; Tzung Lieh Yeh; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.

Authors:  Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Liang-Jen Wang; Po See Chen; Shih-Heng Chen; Chun-Hsien Chu; San-Yuan Huang; Nian-Sheng Tzeng; Chia-Ling Li; Yi-Lun Chung; Tsai-Hsin Hsieh; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.